34 results on '"Florian M. E. Wagenlehner"'
Search Results
2. ACSS-eDiary to self-monitor symptomatic episodes and therapeutic outcome of uncomplicated cystitis
3. Acute uncomplicated cystitis: Do we follow guidelines?
4. Evaluation of the proposed update of FDA guidelines on the symptomatic diagnosis of acute uncomplicated cystitis in women
5. Activation of IRAK1 by uropathogenic E.coli and its overexpression in prostate cancer is regulated by DNA methylation
6. Transurethral resection of the prostate: Are we following the guidelines? Outcomes from the Global Prevalence of Infections in Urology (GPIU) side study 2006-2009
7. The adherence to European Association of Urology guidelines on urological infection in a tertiary referral hospital is the right way for increasing the antimicrobial stewardship among general practitioners
8. Morbidity and mortality outcomes in urosepsis compared according to new sepsis definitions: A prospective multinational observational study – systemic inflammatory response syndrome protects its value
9. Risk factors in urosepsis associated with time to recovery: A prospective multinational observational study
10. A Pilot study to evaluate Next Generation DNA Sequencing Testing in rectal swabs prior to transrectal prostate biopsy
11. 46 Ability of plant extracts to reactivate epigenetically silenced genes in prostate cancer cells
12. 819 Expression of Ten-Eleven-Translocation (TET) enzymes in human spermatogenesis and their role for male fertility
13. 267 Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: Fosfomycin trometamol is an attractive strategy
14. 261 Epigenetic deregulation of CXCL12 and its receptor CXCR4 in CP/CPPS patients
15. 300 Association of CP/CPPS with impaired semen parameters: Does chronic prostatitis affect male fertility?
16. 167 The pivotal role of TET enzymes in epigenetic inactivation of the tumor suppressor RASSF10 in prostate cancer
17. 280 Epigenetic regulation of fibulin-2 in prostate cancer
18. 139 Viral epididymitis and orchitis – myth or reality?
19. 511 EPIGENETIC SILENCING OF RASSF10 IN PROSTATE CANCER AND ITS FUNCTIONAL CONSEQUENCES
20. 568 Epigenetical analyses on inflammatory factors in patients with prostatitis, BPH and prostate cancer: Discovering the link between inflammation and carcinogenesis
21. 846 Hif-1α induced gene activation in course of H3k9me3-depletion is significantly modulated by CpG-promoter methylation
22. 449 Clinical properties of multi & extensive drug resistance Enterobacteriaceae in urosepsis: Outcome of the global prevalence of infections in urology (GPIU) study: 9 Year results of a multinational, multicenter study
23. 741 Complexity measures and classifiers in objective prostate cancer grading
24. 254 Impact of metabolic syndrome on seminal inflammation and sperm parameters: A case-control study
25. 947 Distinct role of the CTCF-binding site in IGF2/H19-ICR and of the differential methylated region in IGF2-promoter 0 in LOI and IGF2-expression in prostate cancer
26. 192 Urinary antibacterial activity of nitroxolin 250 mg versus trimethoprim 200 mg against uropathogens after single oral administration
27. 46 Empiric antibiotic therapy in acute epididymitis: Are guideline recommendations adequate?
28. 297 Multi-drug resistant hospital acquired urinary tract isolates: Prevalence and demographic properties: Outcome of the Global Prevalence of Infections in Urology (GPIU) Study: Six year results of a multinational, multicenter study
29. 367 TESTPSYCHOLOGICAL INTERACTIONS BETWEEN NIH-CPSI AND IPSS, HADS-D, AND IIEF RESULTS: ASSOCIATIONS TO LUTS, DEPRESSION, AND ERECTILE DYSFUNCTION IN MEN WITH CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME (CP/CPPS)
30. 746 EPIGENETIC INACTIVATION OF RASSF10, A NOVEL MEMBER OF RAS ASSOCIATION DOMAIN FAMILY, IN PROSTATE CANCER
31. 559 LONG TERM EFFICACY OF CERNILTON IN PATIENTS WITH CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME TYPE NIH IIIA
32. 551 CORRELATION OF INFLAMMATORY AND SPERM QUALITY PARAMETERS IN PATIENTS WITH CP/CPPS AND INFERTILE PATIENTS
33. URINARY BACTERICIDAL ACTIVITY OF DORIPENEM VERSUS LEVOFLOXACIN IN PATIENTS WITH COMPLICATED URINARY TRACT INFECTIONS OR PYELONEPHRITIS
34. PLASMA CONCENTRATIONS, URINARY EXCRETION AND BACTERICIDAL ACTIVITY OF CIPROFLOXACIN XR (1000 MG) VERSUS LEVOFLOXACIN (500 MG) IN HEALTHY VOLUNTEERS RECEIVING A SINGLE ORAL DOSE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.